Counterpart Health,a wholly owned subsidiary of Clover Health (CLOV) Investments, announced a major upgrade to Counterpart Assistant: the launch of its fully integrated ambient scribing solution. “Our goal has always been to deliver clinical insights directly into the physician’s workflow, supporting better care and making every encounter more seamless,” said Conrad Wai, CEO of Counterpart Health. “By bringing scribing into value-based care, we are enabling clinicians to focus on managing care, rather than keeping up with documentation.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLOV:
- Unusually active option classes on open September 8th
- Optimistic Buy Rating for Clover Health Investments Driven by Medicare Advantage Growth and Effective Cost Management
- Clover Health Investments: Strategic Growth and Operational Efficiencies Drive Buy Rating
- Clover Health Engages Shareholders with FAQ Release
- Clover Health price target lowered to $4.10 from $4.50 at Canaccord